{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:45:21Z","timestamp":1793832321279,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.eprac.2024.01.013","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T03:21:19Z","timestamp":1706844079000},"page":"441-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Characteristics and Management of Cosecreting Thyroid Stimulating Hormone or Prolactin Pituitary Growth Hormone Adenomas: A Case-Control Study"],"prefix":"10.1016","volume":"30","author":[{"given":"Caiyan","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbai","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl_5","key":"10.1016\/j.eprac.2024.01.013_bib1","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/now207","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.eprac.2024.01.013_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.eprac.2024.01.013_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-21-0216","article-title":"Global epidemiology of acromegaly: a systematic review and meta-analysis","volume":"185","author":"Crisafulli","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2024.01.013_bib4","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s40618-019-01066-x","article-title":"A\u00a02019 update on TSH-secreting pituitary adenomas","volume":"42","author":"Beck-Peccoz","year":"2019","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.eprac.2024.01.013_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/723432","article-title":"Clinicopathological features of growth hormone-producing pituitary adenomas in 242 acromegaly patients: classification according to hormone production and cytokeratin distribution","volume":"2013","author":"Mori","year":"2013","journal-title":"ISRN Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2024.01.013_bib6","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/EJE-21-0162","article-title":"Endocrine tumours: thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases","volume":"185","author":"De Herdt","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.eprac.2024.01.013_bib7","first-page":"1021","article-title":"The cardiovascular system in growth hormone excess and growth hormone deficiency","volume":"35","author":"Lombardi","year":"2012","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.eprac.2024.01.013_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO Classification of Pituitary Tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"issue":"6","key":"10.1016\/j.eprac.2024.01.013_bib9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","article-title":"Clinical biology of the pituitary adenoma","volume":"43","author":"Melmed","year":"2022","journal-title":"Endocr Rev"},{"issue":"11","key":"10.1016\/j.eprac.2024.01.013_bib10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","article-title":"Acromegaly: pathogenesis, diagnosis, and management","volume":"10","author":"Fleseriu","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2024.01.013_bib11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/jcem-62-4-704","article-title":"Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity","volume":"62","author":"Beck-Peccoz","year":"1986","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2024.01.013_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11102-020-01064-w","article-title":"Cosecreting TSH\/GH pituitary adenomas-an 8-year experience in a single tertiary center","volume":"23","author":"Li","year":"2020","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.eprac.2024.01.013_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s11102-020-01075-7","article-title":"Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly","volume":"23","author":"Varlamov","year":"2020","journal-title":"Pituitary"},{"issue":"5","key":"10.1016\/j.eprac.2024.01.013_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1530\/EJE-11-1119","article-title":"The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases","volume":"166","author":"Wang","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2024.01.013_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF03346583","article-title":"Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: the intriguing case of Mister B","volume":"33","author":"Curto","year":"2010","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.eprac.2024.01.013_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11102-005-3279-2","article-title":"Dramatic volume reduction of a large GH\/TSH secreting pituitary tumor with short term Octreotide therapy","volume":"8","author":"Atkinson","year":"2005","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.eprac.2024.01.013_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3803\/EnM.2015.30.3.389","article-title":"Acromegaly due to a macroinvasive plurihormonal pituitary adenoma and a rectal carcinoid tumor","volume":"30","author":"Chin","year":"2015","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"3","key":"10.1016\/j.eprac.2024.01.013_bib18","first-page":"403","article-title":"Thyrotropin secreting pituitary adenoma accompanying a silent somatotropinoma","volume":"21","author":"Berker","year":"2011","journal-title":"Turk Neurosurg"},{"key":"10.1016\/j.eprac.2024.01.013_bib19","article-title":"Thyrotoxicosis with absence of clinical features of acromegaly in a TSH- and GH-secreting, invasive pituitary macroadenoma","volume":"2015","author":"Johnston","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"10.1016\/j.eprac.2024.01.013_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12022-015-9395-2","article-title":"Monomorphous plurihormonal pituitary adenoma of Pit-1 lineage in a giant adolescent with central hyperthyroidism","volume":"27","author":"Pereira","year":"2016","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.eprac.2024.01.013_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-010-9341-5","article-title":"A\u00a0case of fugitive acromegaly, initially presented as invasive prolactinoma","volume":"38","author":"Lim","year":"2010","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.eprac.2024.01.013_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jocn.2004.05.011","article-title":"Silent pituitary macroadenoma co-secreting growth hormone and thyroid stimulating hormone","volume":"12","author":"Sen","year":"2005","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.eprac.2024.01.013_bib23","first-page":"EDM190068","article-title":"Clinical challenges of a co-secreting TSH\/GH pituitary adenoma","volume":"2019","author":"Ng","year":"2019","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"5","key":"10.1016\/j.eprac.2024.01.013_bib24","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1210\/clinem\/dgac675","article-title":"Dissecting the in vitro efficacy of octreotide and cabergoline in GH- and GH\/PRL-secreting pituitary tumors","volume":"108","author":"Gatto","year":"2023","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2024.01.013_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12020-016-0863-3","article-title":"Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management","volume":"52","author":"Amlashi","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.eprac.2024.01.013_bib26","first-page":"18","article-title":"A\u00a0case of a co-secreting TSH and growth hormone pituitary adenoma presenting with a thyroid nodule","volume":"2018","author":"Adams","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"6","key":"10.1016\/j.eprac.2024.01.013_bib27","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1210\/jc.2013-4376","article-title":"Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation","volume":"99","author":"Malchiodi","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2024.01.013_bib28","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.4158\/EP13036.CR","article-title":"Unexpected clinical course during treatment of a TSH-secreting pituitary adenoma","volume":"19","author":"Glynn","year":"2013","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.eprac.2024.01.013_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/eje.0.1490017","article-title":"Development of acromegaly in patients with prolactinomas","volume":"149","author":"Andersen","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2024.01.013_bib30","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1590\/S0004-27302010000600006","article-title":"Biochemical acromegaly in patients with prolactinoma during treatment with dopaminergic agonists","volume":"54","author":"Rosario","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.eprac.2024.01.013_bib31","first-page":"16","article-title":"Late presentation of acromegaly in medically controlled prolactinoma patients","volume":"2016","author":"Manuylova","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2400048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2400048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:48:28Z","timestamp":1722890908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2400048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1530891X2400048X"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.01.013","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Characteristics and Management of Cosecreting Thyroid Stimulating Hormone or Prolactin Pituitary Growth Hormone Adenomas: A Case-Control Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}